Rapidly Progressive Lung Sarcomatoid Carcinoma Managed with Doxorubicin Plus Ifosfamide and Pemetrexed

Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of nonsmall-cell lung cancer (NSCLC). It carries a poor prognosis, even among other subtypes of NSCLC. Currently, most treatment strategies for PSC are derived from regimens aimed at managing soft tissue sarcomas or NSCLC. The use of doxorubici...

Descripción completa

Detalles Bibliográficos
Autores principales: Paredes Mogica, Jan Alberto, Reyes Sanchez, Eduardo, Zaragoza Morales, Daniela Arantza, Pierre-Louis Guillen, Nathalie, Magallanes Maciel, Manuel Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740224/
https://www.ncbi.nlm.nih.gov/pubmed/35082625
http://dx.doi.org/10.1159/000520190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740224/
https://www.ncbi.nlm.nih.gov/pubmed/35082625
http://dx.doi.org/10.1159/000520190

Ejemplares similares